Therapy News and Research

RSS

Researchers launch study to determine effects of increased access to rapid COVID-19 testing

Researchers at the University of Chicago Medicine and the University of Illinois at Chicago (UIC) are launching an investigational study to determine the effects of increased education and access to rapid, FDA-approved COVID-19 testing on community perceptions, access, and use of COVID-19 testing resources.

24 Nov 2020

IU research could lead to improved breast cancer treatments for Black women

An Indiana University Melvin and Bren Simon Comprehensive Cancer Center researcher is identifying the unique biology that may make Black women more susceptible to aggressive breast cancer.

24 Nov 2020

Study finds how the brain 're-wires' after neurological disease

Trinity College researchers are studying how the brain re-wires itself in neurological disease.

24 Nov 2020

Potential treatment could reduce heart failure after a significant heart attack

While there are therapies to aid in overall heart health, there are very few preventative therapies for heart failure after a significant heart attack, a serious condition that has a very significant mortality.

24 Nov 2020

Sex steroids may play a protective role in COVID-19, shows study

A new paper from a UIC researcher shows evidence that suggests sex steroids may play a role in protecting against COVID-19 symptoms.

24 Nov 2020

New legal push aims to speed magic mushrooms to dying patients

Back in March, just as anxiety over COVID-19 began spreading across the U.S., Erinn Baldeschwiler of La Conner, Washington, found herself facing her own private dread.

24 Nov 2020

New therapy developed for flu infections may also prove effective against HIV, COVID-19

A new therapy for influenza virus infections that may also prove effective against many other pathogenic virus infections, including HIV and COVID-19, has been developed by Purdue University scientists.

24 Nov 2020

Treatment of mental health issues neglected during stroke recovery

The health system is failing to recognize the importance of treating mental health issues in stroke recovery.

24 Nov 2020

Researchers assess benefits of magnetic seizure therapy to treat depression in bipolar patients

Researchers are assessing whether magnetic seizure therapy (MST) can help relieve treatment-resistant depression in bipolar patients in a clinical trial led by The University of Texas Health Science Center at Houston (UTHealth).

24 Nov 2020

Study: Home health care provides support, improves recovery for COVID-19 patients

Survivors of COVID-19 are a vulnerable population who often have health ramifications from their illness and hospital stay. Upon returning home from acute care, large proportions of survivors experience functional dependencies, pain, dyspnea, and exhaustion.

24 Nov 2020

COVID-19 severity is higher in male cancer patients compared to females

Men with cancer and COVID-19 may be at significantly higher risk for severe symptoms and even death as compared to females fighting both, a University of Kansas Cancer Center research team has found.

23 Nov 2020

Unique training program is bolstering Canada’s capacity to manufacture novel biotherapeutics

As COVID-19 highlights the urgent need to increase vaccine manufacturing around the world, a unique training program is bolstering Canada's capacity to manufacture vaccines, as well as viral immunotherapies for cancer and other emerging biotherapeutics.

23 Nov 2020

First checkpoint inhibitor vaccine shown to be safe, effective in colon cancer animal model

A study led by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute described a potential therapeutic anticancer vaccine that frees suppressed cancer-killing immune cells, enabling them to attack and destroy a tumor.

23 Nov 2020

Cutting edge technology used to bioprint miniature human kidneys in the lab

Researchers have used cutting edge technology to bioprint miniature human kidneys in the lab, paving the way for new treatments for kidney failure and possibly lab-grown transplants.

23 Nov 2020

Septic shock and pneumonia triggered by SARS-CoV-2 could be treated by radiation-activated MSCs

This study, published in the journal Cells, is based on others (all of which employed experimental models) previously conducted by researchers at the Biomedical Research Centre of the University of Granada, the ‘López-Neyra’ Institute of Parasitology and Biomedicine, and the ‘Virgen de las Nieves’ University Hospital in Granada

23 Nov 2020

University of Sheffield and Pfizer launch new consortium to accelerate development of ATMPs

The University of Sheffield and Pfizer have today (23 November 2020) launched a new consortium which aims to standardize and accelerate the development of Advanced Therapy Medicinal Products (ATMPs), allowing potentially transformative treatments to reach patients sooner.

23 Nov 2020

Reprogramming T cells into highly active 'super immune cells' can improve immunotherapy benefits

Immune-system T cells have been reprogrammed into regenerative stem cell-like memory (TSCM) cells that are long-lived, highly active "super immune cells" with strong antitumor activity, according to new research from Georgetown Lombardi Comprehensive Cancer Center.

23 Nov 2020

Novel targeted therapy blocks metabolic pathways in cancer cells with specific genetic defects

Researchers at The University of Texas MD Anderson Cancer Center have developed a novel targeted therapy, called POMHEX, which blocks critical metabolic pathways in cancer cells with specific genetic defects.

23 Nov 2020

Study assesses impact of social needs on African American cancer survivors

Social needs--such as food and economic insecurity, poor housing and neighborhood conditions, and lack of access to transportation--were common in a group of African American cancer survivors in Detroit, and they were associated with lower health-related quality of life (HRQOL).

23 Nov 2020

FDA schedules meeting to discuss emergency use authorization of COVID-19 vaccine from Pfizer

Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for casirivimab and imdevimab to be administered together for the treatment of mild to moderate COVID-19 in adults and pediatric patients (12 years of age or older weighing at least 40 kilograms [about 88 pounds]) with positive results of direct SARS-CoV-2 viral testing and who are at high risk for progressing to severe COVID-19.

23 Nov 2020

Therapy News and Research

Researchers launch study to determine effects of increased access to rapid COVID-19 testing

IU research could lead to improved breast cancer treatments for Black women

Study finds how the brain 're-wires' after neurological disease

Potential treatment could reduce heart failure after a significant heart attack

Sex steroids may play a protective role in COVID-19, shows study

New legal push aims to speed magic mushrooms to dying patients

New therapy developed for flu infections may also prove effective against HIV, COVID-19

Treatment of mental health issues neglected during stroke recovery

Researchers assess benefits of magnetic seizure therapy to treat depression in bipolar patients

Study: Home health care provides support, improves recovery for COVID-19 patients

COVID-19 severity is higher in male cancer patients compared to females

Unique training program is bolstering Canada’s capacity to manufacture novel biotherapeutics

First checkpoint inhibitor vaccine shown to be safe, effective in colon cancer animal model

Cutting edge technology used to bioprint miniature human kidneys in the lab

Septic shock and pneumonia triggered by SARS-CoV-2 could be treated by radiation-activated MSCs

University of Sheffield and Pfizer launch new consortium to accelerate development of ATMPs

Reprogramming T cells into highly active 'super immune cells' can improve immunotherapy benefits

Novel targeted therapy blocks metabolic pathways in cancer cells with specific genetic defects

Study assesses impact of social needs on African American cancer survivors

FDA schedules meeting to discuss emergency use authorization of COVID-19 vaccine from Pfizer

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News